Information  X 
Enter a valid email address

Intelligent Ultrasnd (IUG)

  Print          Annual reports

Wednesday 15 September, 2021

Intelligent Ultrasnd

Directorate Change

RNS Number : 7818L
Intelligent Ultrasound Group PLC
15 September 2021

15 September 2021


Intelligent Ultrasound Group plc

("IUG" or the "Company" or the "Group")


Directorate Change

Appointment of Michele Lesieur to Board


Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces that Michele Lesieur will be joining the Board as a Non-executive Director with effect from 20 September 2021.

Michele brings to the Company outstanding industry, corporate governance, and investor relations experience, having been CEO of Philips France and General Manager of Philips Healthcare France and most recently CEO of Euronext listed Supersonic Imagine, that was sold to Hologic in 2019 and Non-executive Director of EOS Imaging, a listed software medtech company, sold to Nasdaq listed Alphatec Holdings, Inc in 2021.

Michele remains Chairman of the Board of Intrasense, a listed software medtech company and Non-executive Director of Prodways Group, a listed 3D printing company.

Riccardo Pigliucci, Chairman of Intelligent Ultrasounds Group plc said : "I am delighted that Michele has chosen to join Intelligent Ultrasound as a Non-executive Director. She was an exceptional candidate for the position, with outstanding commercial experience in the medical imaging sector and her wealth of knowledge and understanding of the major imaging manufacturers can only benefit the Group, as we continue to expand our classroom to the clinic ultrasound business."

The following details in relation to the appointment of Michele Jeanine   Lesieur (formerly Lucas), aged 61, are disclosed in accordance with Schedule 2(g) of the AIM Rules:

Current directorships

Directorships held within the last five years

Intrasense SA


Supersonic Imagine SA

Prodways Group SA

SuperSonic Imagine Inc


SuperSonic Imagine Ltd


SuperSonic Imagine Gmbh


SuperSonic Imagine Srl


SuperSonic Imagine HK Ltd


SuperSonic Imagine (Shangai) Medical Devices Co. Ltd


EOS Imaging SA



For further information, please contact:


Intelligent Ultrasound Group plc 


Stuart Gall, CEO 
Helen Jones, CFO

Tel: +44 (0)29 2075 6534 



Cenkos Securities - Nominated Advisor and Broker

Tel:  +44 (0)20 7397 8900 

Giles Balleny / Max Gould (Corporate Finance)


Dale Bellis / Julian Morse (Sales) 




Walbrook PR 

Tel: +44 (0)20 7933 8780 or  [email protected]  

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893



About Intelligent Ultrasound Group


Intelligent Ultrasound (AIM: IUG) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:


Clinical AI Division


Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include :


ScanNav Assist

ScanNav Assist uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received CE and FDA regulatory approval. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.


ScanNav Anatomy

ScanNav Anatomy PNB uses machine-learning based algorithms to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy  highlighting software for a range of medical procedures. ScanNav Anatomy has received CE approval and has also been submitted for FDA regulatory approval.


ScanNav Anatomy PNB is therefore not available for sale in the US or any other territory requiring government approval for this type of product.


Simulation Division 


Focusses on hi-fidelity ultrasound education and training through simulation.  Its main products are the  ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new AI-based Anatomy PNB training simulator. To date over 1,000 simulators have been sold to over 600 medical institutions around the world.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t